Advances in adult asthma diagnosis and treatment in 2012: Potential therapeutics and gene-environment interactions

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 1, 2013, Pages 47-54

  Apter, Andrea J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adults; Asthma; biomarkers; gene environment interaction; inhaled corticosteroids; long acting agonist

Indexed keywords

ANTIRETROVIRUS AGENT; B CELL ACTIVATING FACTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; EOTAXIN; FILAGGRIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 32; INTERLEUKIN 4; INTERLEUKIN 8; INTERLEUKIN 9; MEPOLIZUMAB; MITOGEN ACTIVATED PROTEIN KINASE; MONTELUKAST; MUSCARINIC RECEPTOR BLOCKING AGENT; OMALIZUMAB; RANTES; RESLIZUMAB; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT DISEASE; ALLELE; ARTICLE; ASTHMA; BIRTH DEFECT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLIMATE CHANGE; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DRUG MEGADOSE; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FOOD ALLERGY; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; POLLUTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; T LYMPHOCYTE; TREATMENT RESPONSE;

ADULT; ASTHMA; ENVIRONMENTAL EXPOSURE; GENE-ENVIRONMENT INTERACTION; HUMANS;

EID: 84871837414     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.11.020     Document Type: Article

References (73)

1. A.J. Apter Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2011: what goes around comes around J Allergy Clin Immunol 129 2012 69 75
2. S.J. Szefler Advances in pediatric asthma in 2011: moving forward J Allergy Clin Immunol 129 2012 60 68
3. C.S. Farah, G.G. King, N.J. Brown, S.R. Downie, J.A. Kermode, and K.M. Hardaker The role of the small airways in the clinical expression of asthma in adults J Allergy Clin Immunol 129 2012 381 387.e1
4. P.J. Chang, P.K. Bhavsar, C. Michaeloudes, N. Khorasani, and K.F. Chung Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma J Allergy Clin Immunol 130 2012 877 885.e5
5. N. Meyer, J. Christoph, H. Makrinioti, P. Indermitte, C. Rhyner, and M. Soyka Inhibition of angiogenesis by IL-32: possible role in asthma J Allergy Clin Immunol 129 2012 964 973.e7
6. C.P. Jones, L.G. Gregory, B. Causton, G.A. Campbell, and C.M. Lloyd Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology J Allergy Clin Immunol 129 2012 1000 1010.e3
7. A. Munitz, and P.S. Foster T(H)9 cells: in front and beyond T(H)2 J Allergy Clin Immunol 129 2012 1011 1013
8. R.N. Bauer, L.E. Brighton, L. Mueller, Z. Xiang, J.E. Rager, and R.C. Fry Influenza enhances caspase-1 in bronchial epithelial cells from asthmatic volunteers and is associated with pathogenesis J Allergy Clin Immunol 130 2012 958 967.e14
9. M.L. Hernandez, M. Herbst, J.C. Lay, N.E. Alexis, W.J. Brickey, and J.P. Ting Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers J Allergy Clin Immunol 130 2012 869 876.e2
10. R. Kumar, L.K. Williams, A. Kato, E.L. Peterson, S. Favoreto Jr., and K. Hulse Genetic variation in B cell-activating factor of the TNF family (BAFF) and asthma exacerbations among African American subjects J Allergy Clin Immunol 130 2012 996 999.e6
11. N.D. Berg, L.L. Husemoen, B.H. Thuesen, L.G. Hersoug, J. Elberling, and J.P. Thyssen Interaction between filaggrin null mutations and tobacco smoking in relation to asthma J Allergy Clin Immunol 129 2012 374 380 e1-2
12. S.J. Arbes Jr. Do all asthmatics with atopy have atopic asthma? J Allergy Clin Immunol 130 2012 1202 1204
13. R. Du, A.A. Litonjua, K.G. Tantisira, J. Lasky-Su, S.R. Sunyaev, and B.J. Klanderman Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations J Allergy Clin Immunol 129 2012 368 373 e1-5
14. E. Tsitsiou, A.E. Williams, S.A. Moschos, K. Patel, C. Rossios, and X. Jiang Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma J Allergy Clin Immunol 129 2012 95 103
15. S.F. Ziegler Thymic stromal lymphopoietin and allergic disease J Allergy Clin Immunol 130 2012 845 852
16. A. Shikotra, D.F. Choy, C.M. Ohri, E. Doran, C. Butler, and B. Hargadon Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma J Allergy Clin Immunol 129 2012 104 111 e1-9
17. R. Chaudhuri, C. McSharry, J. Brady, I. Donnelly, C. Grierson, and S. McGuinness Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity J Allergy Clin Immunol 129 2012 655 663.e8
18. X. Li, E.J. Ampleford, T.D. Howard, W.C. Moore, D.G. Torgerson, and H. Li Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases J Allergy Clin Immunol 130 2012 861 868.e7
19. R.A. Myers, B.E. Himes, C.R. Gignoux, J.J. Yang, W.J. Gauderman, and C. Rebordosa Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans J Allergy Clin Immunol 2012 [Epub ahead of print]
20. F. Kauffmann, and F. Demenais Gene environment interactions in asthma and allergic diseases: challenges and perspectives J Allergy Clin Immunol 2012 [Epub ahead of print]
21. D. Daley, J.E. Park, J.Q. He, J. Yan, L. Akhabir, and D. Stefanowicz Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes J Allergy Clin Immunol 2012 [Epub ahead of print]
22. G. Wegienka, C.L. Joseph, S. Havstad, E. Zoratti, D. Ownby, and C.C. Johnson Sensitization and allergic histories differ between black and white pregnant women J Allergy Clin Immunol 130 2012 657 662.e2
23. J.A. Rumpel, B.K. Ahmedani, E.L. Peterson, K.E. Wells, M. Yang, and A.M. Levin Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma J Allergy Clin Immunol 2012 [Epub ahead of print]
24. D.K. Ledford, A.W. Burks, M. Ballow, L. Cox, R.A. Wood, and T.B. Casale Statement regarding "The public health benefits of air pollution control." J Allergy Clin Immunol 130 2012 24
25. J. Li, G. Ewart, M. Kraft, and P.W. Finn The public health benefits of air pollution control J Allergy Clin Immunol 130 2012 22 23
26. R.J. Laumbach, and H.M. Kipen Respiratory health effects of air pollution: update on biomass smoke and traffic pollution J Allergy Clin Immunol 129 2012 3 13
27. T.F. Leung, F.W. Ko, and G.W. Wong Roles of pollution in the prevalence and exacerbations of allergic diseases in Asia J Allergy Clin Immunol 129 2012 42 47
28. R.N. Bauer, D. Diaz-Sanchez, and I. Jaspers Effects of air pollutants on innate immunity: the role of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors J Allergy Clin Immunol 129 2012 14 26
29. H. Ji, and G.K. Khurana Hershey Genetic and epigenetic influence on the response to environmental particulate matter J Allergy Clin Immunol 129 2012 33 41
30. I.V. Yang, and D.A. Schwartz Epigenetic mechanisms and the development of asthma J Allergy Clin Immunol 2012 [Epub ahead of print]
31. L.H. Ziska, and P.J. Beggs Anthropogenic climate change and allergen exposure: the role of plant biology J Allergy Clin Immunol 129 2012 27 32
32. A.P. Knutsen, R.K. Bush, J.G. Demain, D.W. Denning, A. Dixit, and A. Fairs Fungi and allergic lower respiratory tract diseases J Allergy Clin Immunol 129 2012 280 293
33. D. Heederik, and E. von Mutius Does diversity of environmental microbial exposure matter for the occurrence of allergy and asthma? J Allergy Clin Immunol 130 2012 44 50
34. E. von Mutius A fascinating look at the world with a new microscope J Allergy Clin Immunol 129 2012 1202 1203
35. L.K. Ursell, J.C. Clemente, J.R. Rideout, D. Gevers, J.G. Caporaso, and R. Knight The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites J Allergy Clin Immunol 129 2012 1204 1208
36. V. Bougault, L. Loubaki, P. Joubert, J. Turmel, C. Couture, and M. Laviolette Airway remodeling and inflammation in competitive swimmers training in indoor chlorinated swimming pools J Allergy Clin Immunol 129 2012 351 358.e1
37. A. Gershon, J. Guan, J.C. Victor, C. Wang, and T. To The course of asthma activity: a population study J Allergy Clin Immunol 129 2012 679 686
38. D. Koinis-Mitchell, T. Craig, C.A. Esteban, and R.B. Klein Sleep and allergic disease: a summary of the literature and future directions for research J Allergy Clin Immunol 2012 [Epub ahead of print]
39. M.R. Gingo, S.E. Wenzel, C. Steele, C.J. Kessinger, L. Lucht, and T. Lawther Asthma diagnosis and airway bronchodilator response in HIV-infected patients J Allergy Clin Immunol 129 2012 708 714.e8
40. W.W. Busse, W.J. Morgan, V. Taggart, and A. Togias Asthma outcomes workshop: overview J Allergy Clin Immunol 129 suppl 2012 S1 S8
41. L.J. Akinbami, S.D. Sullivan, J.D. Campbell, R.W. Grundmeier, T.V. Hartert, and T.A. Lee Asthma outcomes: healthcare utilization and costs J Allergy Clin Immunol 129 suppl 2012 S49 S64
42. M.M. Cloutier, M. Schatz, M. Castro, N. Clark, H.W. Kelly, and R. Mangione-Smith Asthma outcomes: composite scores of asthma control J Allergy Clin Immunol 129 suppl 2012 S24 S33
43. A. Fuhlbrigge, D. Peden, A.J. Apter, H.A. Boushey, C.A. Camargo Jr., and J. Gern Asthma outcomes: exacerbations J Allergy Clin Immunol 129 suppl 2012 S34 S48
44. J.A. Krishnan, R.F. Lemanske Jr., G.J. Canino, K.S. Elward, M. Kattan, and E.C. Matsui Asthma outcomes: symptoms J Allergy Clin Immunol 129 suppl 2012 S124 S135
45. C.S. Rand, R.J. Wright, M.D. Cabana, M.B. Foggs, J.S. Halterman, and L. Olson Mediators of asthma outcomes J Allergy Clin Immunol 129 suppl 2012 S136 S141
46. S.J. Szefler, S. Wenzel, R. Brown, S.C. Erzurum, J.V. Fahy, and R.G. Hamilton Asthma outcomes: biomarkers J Allergy Clin Immunol 129 suppl 2012 S9 S23
47. R.S. Tepper, R.S. Wise, R. Covar, C.G. Irvin, C.M. Kercsmar, and M. Kraft Asthma outcomes: pulmonary physiology J Allergy Clin Immunol 129 suppl 2012 S65 S87
48. S.R. Wilson, C.S. Rand, M.D. Cabana, M.B. Foggs, J.S. Halterman, and L. Olson Asthma outcomes: quality of life J Allergy Clin Immunol 129 suppl 2012 S88 S123
49. K. Sumino, E.A. Sugar, C.G. Irvin, D.A. Kaminsky, D. Shade, and C.Y. Wei Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications J Allergy Clin Immunol 130 2012 69 75.e6
50. J.L. Ingram, and M. Kraft IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies J Allergy Clin Immunol 130 2012 829 842
51. P. Nair, and M. Kraft Serum periostin as a marker of T(H)2-dependent eosinophilic airway inflammation J Allergy Clin Immunol 130 2012 655 656
52. G. Jia, R.W. Erickson, D.F. Choy, S. Mosesova, L.C. Wu, and O.D. Solberg Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients J Allergy Clin Immunol 130 2012 647 654.e10
53. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
54. E. Goleva, L.P. Jackson, M. Gleason, and D.Y. Leung Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients J Allergy Clin Immunol 129 2012 687 693.e1
55. C. Bime, C.Y. Wei, J.T. Holbrook, M.M. Sockrider, D.A. Revicki, and R.A. Wise Asthma Symptom Utility Index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients J Allergy Clin Immunol 130 2012 1078 1084
56. S.R. Wilson Adding measures to the asthma outcome measurement toolbox: new findings, new issues J Allergy Clin Immunol 130 2012 1085 1086
57. S. Greenberg, N. Liu, A. Kaur, M. Lakshminarayanan, Y. Zhou, and L. Nelsen The Asthma Disease Activity Score: a discriminating, responsive measure predicts future asthma attacks J Allergy Clin Immunol 130 2012 1071 1077.e10
58. J.J. Wildfire, P.J. Gergen, C.A. Sorkness, H.E. Mitchell, A. Calatroni, and M. Kattan Development and validation of the Composite Asthma Severity Index-an outcome measure for use in children and adolescents J Allergy Clin Immunol 129 2012 694 701
59. Expert Panel Report-3: guidelines for the diagnosis and management of asthma. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed October 18, 2012.
60. C. Rosas-Salazar, A.J. Apter, G. Canino, and J.C. Celedon Health literacy and asthma J Allergy Clin Immunol 129 2012 935 942
61. M. Patel, J. Pilcher, A. Chan, K. Perrin, P. Black, and R. Beasley Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use J Allergy Clin Immunol 2012 [Epub ahead of print]
62. S.T. Weiss New approaches to personalized medicine for asthma: where are we? J Allergy Clin Immunol 129 2012 327 334
63. W.J. Calhoun, B.T. Ameredes, T.S. King, N. Icitovic, E.R. Bleecker, and M. Castro Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial JAMA 308 2012 987 997
64. P.J. Barnes Severe asthma: advances in current management and future therapy J Allergy Clin Immunol 129 2012 48 59
65. H.A. Kerstjens, M. Engel, R. Dahl, P. Paggiaro, E. Beck, and M. Vandewalker Tiotropium in asthma poorly controlled with standard combination therapy N Engl J Med 367 2012 1198 1207
66. I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, and O.N. Keene Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Lancet 380 2012 651 659
67. S. Hashimoto, and E.H. Bel Targeting IL-5 in severe asthma: a DREAM come true? Lancet 380 2012 626 627
68. E. Goleva, D.A. Searing, L.P. Jackson, B.N. Richers, and D.Y. Leung Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma J Allergy Clin Immunol 129 2012 1243 1251
69. W. Busse, R. Buhl, C. Fernandez Vidaurre, M. Blogg, J. Zhu, and M.D. Eisner Omalizumab and the risk of malignancy: results from a pooled analysis J Allergy Clin Immunol 129 2012 983 989.e6
70. L.M. Nelsen, K.E. Shields, M.L. Cunningham, J.M. Stoler, M.J. Bamshad, and P.M. Eng Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications J Allergy Clin Immunol 129 2012 251 254 e1-6
71. E. Ingelsson, L. Yin, and M. Back Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease J Allergy Clin Immunol 129 2012 702 707.e2
72. S. Szefler, and W. Busse The LABA controversy in asthma: troublesome times J Allergy Clin Immunol 2012 [Epub ahead of print]
73. J.L. Brozek, M. Kraft, J.A. Krishnan, M.M. Cloutier, S.C. Lazarus, and J.T. Li Long-acting beta2-agonist step-off in patients with controlled asthma: systematic review with meta-analysis Arch Intern Med 2012 [Epub ahead of print]